Acutus Medical
15
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
40.0%
6 terminated/withdrawn out of 15 trials
57.1%
-29.4% vs industry average
0%
0 trials in Phase 3/4
50%
4 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)
Role: lead
AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)
Role: lead
AcQForce Pulsed Field Ablation-CE
Role: lead
AcQBlate Force Sensing Ablation System US IDE Study for Atrial Fibrillation
Role: lead
AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study)
Role: lead
AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter)
Role: lead
AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation
Role: lead
Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation
Role: lead
AcQBlate Force Confirmatory Study for Atrial Arrhythmias
Role: lead
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation
Role: lead
HCM-AF Ablation With ACUTUS
Role: collaborator
Dipole Density Mapping in Supraventricular Tachycardia
Role: lead
Dipole Density Mapping of Right and Left Atrial Supraventricular Tachycardia
Role: lead
Dipole Density Mapping of Typical Atrial Flutter
Role: lead
Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter
Role: lead
All 15 trials loaded